Sweet, bloody consumption – what we eat and how it affects vascular ageing, the BBB and kidney health in CKD

References

• Crutzen PJ, Stoermer EF. The ‘Anthropocene’. In: Benner S, Lax G, Crutzen P, Pöschl U, Lelieveld J Brauch H. editors. Paul J Crutzen and the Anthropocene: a new epoch in earth’s history. Vol. 2021. US: Springer International Publishing; 2000. pp. 19–26.
   Google Scholar
• Willett W, Rockstrom J, Loken B, Springmann M, Lang T, Vermeulen S, Garnett T, Tilman D, DeClerck F, Wood A. et al. Food in the Anthropocene: the EAT–Lancet Commission on healthy diets from sustainable food systems. Lancet. 2019;393(10170):447–492. doi:10.1016/S0140-6736(18)31788-4.
   PubMed Web of Science ®Google Scholar
• David LA, Maurice CF, Carmody RN, Gootenberg DB, Button JE, Wolfe BE, Ling AV, Devlin AS, Varma Y, Fischbach MA. et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature. 2014;505(7484):559–563. doi:10.1038/nature12820.
   PubMed Web of Science ®Google Scholar
• De Filippo C, Cavalieri D, Di Paola M, Ramazzotti M, Poullet JB, Massart S, Collini S, Pieraccini G, Lionetti P. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl Acad Sci USA. 2010;107(33):14691–14696. doi:10.1073/pnas.1005963107.
   PubMed Web of Science ®Google Scholar
• Candido FG, Valente FX, Grzeskowiak LM, Moreira APB, Rocha D, Alfenas RCG. Impact of dietary fat on gut microbiota and low-grade systemic inflammation: mechanisms and clinical implications on obesity. Int J Food Sci Nutr. 2018;69(2):125–143. doi:10.1080/09637486.2017.1343286.
   PubMed Web of Science ®Google Scholar
• Newsome R, Yang Y, Jobin C. Western diet influences on microbiome and carcinogenesis. Semin Immunol. 2023;67:101756. doi:10.1016/j.smim.2023.101756.
   PubMed Web of Science ®Google Scholar
• Hu EA, Coresh J, Anderson CA, Appel LJ, Grams ME, Crews DC, Mills KT, He J, Scialla J, Rahman M. et al. Adherence to healthy dietary patterns and risk of CKD progression and all-cause mortality: findings from the CRIC (Chronic Renal Insufficiency Cohort) Study. Am J Kidney Dis. 2021;77(2):235–244. doi:10.1053/j.ajkd.2020.04.019.
   PubMed Web of Science ®Google Scholar
• Dai L, Qureshi AR, Witasp A, Lindholm B, Stenvinkel P. Early vascular ageing and cellular senescence in chronic kidney disease. Comput Struct Biotechnol J. 2019;17:721–729. doi:10.1016/j.csbj.2019.06.015.
   PubMed Web of Science ®Google Scholar
• Tonelli M, Wiebe N, Guthrie B, James MT, Quan H, Fortin M, Klarenbach SW, Sargious P, Straus S, Lewanczuk R. et al. Comorbidity as a driver of adverse outcomes in people with chronic kidney disease. Kidney Int. 2015;88(4):859–866. doi:10.1038/ki.2015.228.
   PubMed Web of Science ®Google Scholar
• Ikizler TA, Burrowes JD, Byham-Gray LD, Campbell KL, Carrero J-J, Chan W, Fouque D, Friedman AN, Ghaddar S, Goldstein-Fuchs DJ. et al. KDOQI clinical practice guideline for nutrition in CKD: 2020 update. Am J Kidney Dis. 2020;76(3):S1–S107. doi:10.1053/j.ajkd.2020.05.006.
   PubMed Web of Science ®Google Scholar
• EFSA. Sweeteners. 2023.
   Google Scholar
• Suez J, Korem T, Zeevi D, Zilberman-Schapira G, Thaiss CA, Maza O, Israeli D, Zmora N, Gilad S, Weinberger A. et al. Artificial sweeteners induce glucose intolerance by altering the gut microbiota. Nature. 2014;514(7521):181–186. doi:10.1038/nature13793.
   PubMed Web of Science ®Google Scholar
• Pearlman M, Obert J, Casey L. The association between artificial sweeteners and obesity. Curr Gastroenterol Rep. 2017;19(12):64. doi:10.1007/s11894-017-0602-9.
   PubMedGoogle Scholar
• Yang Q. Gain weight by “going diet?” Artificial sweeteners and the neurobiology of sugar cravings: neuroscience 2010. Yale J Biol Med. 2010;83:101–108.
   PubMedGoogle Scholar
• Buchanan KL, Rupprecht LE, Kaelberer MM, Sahasrabudhe A, Klein ME, Villalobos JA, Liu WW, Yang A, Gelman J, Park S. et al. The preference for sugar over sweetener depends on a gut sensor cell. Nat Neurosci. 2022;25(2):191–200. doi:10.1038/s41593-021-00982-7.
   PubMed Web of Science ®Google Scholar
• Kaelberer MM, Buchanan KL, Klein ME, Barth BB, Montoya MM, Shen X, Bohorquez DV. A gut-brain neural circuit for nutrient sensory transduction. Science. 2018;361(6408):361. doi:10.1126/science.aat5236.
   Web of Science ®Google Scholar
• Liu WW, Bohorquez DV. The neural basis of sugar preference. Nat Rev Neurosci. 2022;23(10):584–595. doi:10.1038/s41583-022-00613-5.
   PubMed Web of Science ®Google Scholar
• Tan HE, Sisti AC, Jin H, Vignovich M, Villavicencio M, Tsang KS, Goffer Y, Zuker CS. The gut–brain axis mediates sugar preference. Nature. 2020;580(7804):511–516. doi:10.1038/s41586-020-2199-7.
   PubMed Web of Science ®Google Scholar
• Lutter M, Nestler EJ. Homeostatic and hedonic signals interact in the regulation of food intake. J Nutr. 2009;139(3):629–632. doi:10.3945/jn.108.097618.
   PubMed Web of Science ®Google Scholar
• Teff KL. How neural mediation of anticipatory and compensatory insulin release helps us tolerate food. Physiol Behav. 2011;103(1):44–50. doi:10.1016/j.physbeh.2011.01.012.
   PubMed Web of Science ®Google Scholar
• Wolnerhanssen BK, Cajacob L, Keller N, Doody A, Rehfeld JF, Drewe J, Peterli R, Beglinger C, Meyer-Gerspach AC. Gut hormone secretion, gastric emptying, and glycemic responses to erythritol and xylitol in lean and obese subjects. Am J Physiol Endocrinol Metab. 2016;310(11):E1053–61. doi:10.1152/ajpendo.00037.2016.
   PubMed Web of Science ®Google Scholar
• Bornet FR, Blayo A, Dauchy F, Slama G. Plasma and urine kinetics of erythritol after oral ingestion by healthy humans. Regul Toxicol Pharmacol. 1996;24(2):S280–5. doi:10.1006/rtph.1996.0109.
   PubMed Web of Science ®Google Scholar
• Ruiz-Ojeda FJ, Plaza-Diaz J, Saez-Lara MJ, Gil A. Effects of sweeteners on the gut microbiota: a review of experimental studies and clinical trials. Adv Nutr. 2019;10:S31–S48. doi:10.1093/advances/nmy037.
   PubMed Web of Science ®Google Scholar
• Gerasimidis K, Bryden K, Chen X, Papachristou E, Verney A, Roig M, Hansen R, Nichols B, Papadopoulou R, Parrett A. et al. The impact of food additives, artificial sweeteners and domestic hygiene products on the human gut microbiome and its fibre fermentation capacity. Eur J Nutr. 2020;59(7):3213–3230. doi:10.1007/s00394-019-02161-8.
   PubMed Web of Science ®Google Scholar
• Karlsson FH, Tremaroli V, Nookaew I, Bergstrom G, Behre CJ, Fagerberg B, Nielsen J, Bäckhed F. Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature. 2013;498(7452):99–103. doi:10.1038/nature12198.
   PubMed Web of Science ®Google Scholar
• Chi L, Bian X, Gao B, Tu P, Lai Y, Ru H, Lu K. Effects of the artificial sweetener neotame on the gut microbiome and fecal metabolites in mice. Molecules. 2018;23(2):367. doi:10.3390/molecules23020367.
   PubMed Web of Science ®Google Scholar
• Abou-Donia MB, El-Masry EM, Abdel-Rahman AA, McLendon RE, Schiffman SS. Splenda alters gut microflora and increases intestinal p-glycoprotein and cytochrome p-450 in male rats. J Toxicol Environ Health A. 2008;71(21):1415–1429. doi:10.1080/15287390802328630.
   PubMed Web of Science ®Google Scholar
• Suez J, Korem T, Zilberman-Schapira G, Segal E, Elinav E. Non-caloric artificial sweeteners and the microbiome: findings and challenges. Gut Microbes. 2015;6(2):149–155. doi:10.1080/19490976.2015.1017700.
   PubMed Web of Science ®Google Scholar
• Ahmad SY, Friel J, Mackay D. The effects of non-nutritive artificial sweeteners, aspartame and sucralose, on the gut microbiome in healthy adults: Secondary outcomes of a randomized double-blinded crossover clinical trial. Nutrients. 2020;12(11):12. doi:10.3390/nu12113408.
   Web of Science ®Google Scholar
• Shil A, Chichger H. Artificial sweeteners negatively regulate pathogenic characteristics of two model gut bacteria, E. coli and E. faecalis. Int J Mol Sci. 2021;22(10):22. doi:10.3390/ijms22105228.
   Web of Science ®Google Scholar
• Markus V, Share O, Shagan M, Halpern B, Bar T, Kramarsky-Winter E, Teralı K, Özer N, Marks RS, Kushmaro A. et al. Inhibitory effects of artificial sweeteners on bacterial quorum sensing. Int J Mol Sci. 2021;22(18):22. doi:10.3390/ijms22189863.
   Web of Science ®Google Scholar
• Yu Z, Wang Y, Henderson IR, Guo J. Artificial sweeteners stimulate horizontal transfer of extracellular antibiotic resistance genes through natural transformation. Isme J. 2022;16(2):543–554. doi:10.1038/s41396-021-01095-6.
   PubMed Web of Science ®Google Scholar
• Naik AQ, Zafar T, Shrivastava VK, Kharat AS. Environmental impact of the presence, distribution, and use of artificial sweeteners as emerging sources of pollution. J Environ Public Health. 2021;2021:1–11. doi:10.1155/2021/6624569.
   Google Scholar
• O’Neill J. Tackling drug-resistant infections globally: final report and recommendations. 2016.
   Google Scholar
• Shil A, Olusanya O, Ghufoor Z, Forson B, Marks J, Chichger H. Artificial sweeteners disrupt tight junctions and barrier function in the intestinal epithelium through activation of the sweet taste receptor, T1R3. Nutrients. 2020;12(6):12. doi:10.3390/nu12061862.
   Web of Science ®Google Scholar
• Stolfi C, Maresca C, Monteleone G, Laudisi F. Implication of intestinal barrier dysfunction in gut dysbiosis and diseases. Biomedicines. 2022;10(2):10. doi:10.3390/biomedicines10020289.
   Web of Science ®Google Scholar
• Karalius VP, Shoham DA. Dietary sugar and artificial sweetener intake and chronic kidney disease: a review. Adv Chronic Kidney Dis. 2013;20(2):157–164. doi:10.1053/j.ackd.2012.12.005.
   PubMed Web of Science ®Google Scholar
• Farid A, Hesham M, El-Dewak M, Amin A. The hidden hazardous effects of stevia and sucralose consumption in male and female albino mice in comparison to sucrose. Saudi Pharm J. 2020;28(10):1290–1300. doi:10.1016/j.jsps.2020.08.019.
   PubMed Web of Science ®Google Scholar
• Enuwosa E, Gautam L, King L, Chichger H. Saccharin and sucralose protect the glomerular microvasculature in vitro against VEGF-induced permeability. Nutrients. 2021;13(8):2746. doi:10.3390/nu13082746.
   PubMed Web of Science ®Google Scholar
• Jacquillet G, Debnam ES, Unwin RJ, Marks J. Acute saccharin infusion has no effect on renal glucose handling in normal rats in vivo. Physiol Rep. 2018;6(14):e13804. doi:10.14814/phy2.13804.
   PubMedGoogle Scholar
• Ardalan MR, Tabibi H, Ebrahimzadeh Attari V, Malek Mahdavi A. Nephrotoxic effect of aspartame as an artificial sweetener: a brief review. Iran J Kidney Dis. 2017;11:339–343.
   PubMed Web of Science ®Google Scholar
• Finamor I, Pavanato MA, Pes T, Ourique G, Saccol E, Schiefelbein S, Llesuy S, Partata W. N-acetylcysteine protects the rat kidney against aspartame-induced oxidative stress. Free Radic Biol Med. 2014;75(Suppl 1):S30. doi:10.1016/j.freeradbiomed.2014.10.759.
   PubMedGoogle Scholar
• Saleh A, Saleh S. Synergistic effect of N-acetylcysteine and folic acid against aspartame-induced nephrotoxicity in rats. Int J Adv Res. 2014;2:363–373.
   Google Scholar
• Martins M, Azoubel R. Effects of aspartame on fetal kidney: a morphometric and stereological study. Int J Morphol. 2007;25(4):689–694. doi:10.4067/S0717-95022007000400004.
   Google Scholar
• Tsang WS, Clarke MA, Parrish FW. Determination of aspartame and its breakdown products in soft drinks by reverse-phase chromatography with UV detection. J Agric Food Chem. 1985;33(4):734–738. doi:10.1021/jf00064a043.
   Web of Science ®Google Scholar
• Nations FaAOotU. Food Balances. 2021.
   Google Scholar
• Bryngelsson D, Wirsenius S, Hedenus F, Sonesson U. How can the EU climate targets be met? A combined analysis of technological and demand-side changes in food and agriculture. Food Policy. 2016;59:152–164. doi:10.1016/j.foodpol.2015.12.012.
   Web of Science ®Google Scholar
• Davison TM, Black JL, Moss JF. Red meat—an essential partner to reduce global greenhouse gas emissions. Anim Front. 2020;10(4):14–21. doi:10.1093/af/vfaa035.
   PubMed Web of Science ®Google Scholar
• Mafra D, Borges NA, Cardozo L, Anjos JS, Black AP, Moraes C, Bergman P, Lindholm B, Stenvinkel P. Red meat intake in chronic kidney disease patients: Two sides of the coin. Nutrition. 2018;46:26–32. doi:10.1016/j.nut.2017.08.015.
   PubMed Web of Science ®Google Scholar
• Wang Y, Uffelman CN, Bergia RE, Clark CM, Reed JB, Cross TL, Lindemann SR, Tang M, Campbell WW. Meat consumption and gut microbiota: a scoping review of literature and systematic review of randomized controlled trials in adults. Adv Nutr. 2023;14(2):215–237. doi:10.1016/j.advnut.2022.10.005.
   PubMed Web of Science ®Google Scholar
• Farvid MS, Sidahmed E, Spence ND, Mante Angua K, Rosner BA, Barnett JB. Consumption of red meat and processed meat and cancer incidence: a systematic review and meta-analysis of prospective studies. Eur J Epidemiol. 2021;36(9):937–951. doi:10.1007/s10654-021-00741-9.
   PubMed Web of Science ®Google Scholar
• Ley SH, Sun Q, Willett WC, Eliassen AH, Wu K, Pan A, Grodstein F, Hu FB. Associations between red meat intake and biomarkers of inflammation and glucose metabolism in women. Am J Clin Nutr. 2014;99(2):352–360. doi:10.3945/ajcn.113.075663.
   PubMed Web of Science ®Google Scholar
• Poore GD, Kopylova E, Zhu Q, Carpenter C, Fraraccio S, Wandro S, Kosciolek T, Janssen S, Metcalf J, Song SJ. et al. Microbiome analyses of blood and tissues suggest cancer diagnostic approach. Nature. 2020;579(7800):567–574. doi:10.1038/s41586-020-2095-1.
   PubMed Web of Science ®Google Scholar
• Craven H, McGuinness D, Buchanan S, Galbraith N, McGuinness DH, Jones B, Combet E, Mafra D, Bergman P, Ellaway A. et al. Socioeconomic position links circulatory microbiota differences with biological age. Sci Rep. 2021;11(1):12629. doi:10.1038/s41598-021-92042-0.
   PubMed Web of Science ®Google Scholar
• Buffa JA, Romano KA, Copeland MF, Cody DB, Zhu W, Galvez R, Fu X, Ward K, Ferrell M, Dai HJ. et al. The microbial gbu gene cluster links cardiovascular disease risk associated with red meat consumption to microbiota L-carnitine catabolism. Nat Microbiol. 2022;7(1):73–86. doi:10.1038/s41564-021-01010-x.
   PubMed Web of Science ®Google Scholar
• Vaziri ND. CKD impairs barrier function and alters microbial flora of the intestine: a major link to inflammation and uremic toxicity. Curr Opin Nephrol Hypertens. 2012;21(6):587–592. doi:10.1097/MNH.0b013e328358c8d5.
   PubMed Web of Science ®Google Scholar
• Craven H, Erlandsson H, McGuinness D, McGuinness DH, Mafra D, Ijaz UZ, Bergman P, Shiels P, Stenvinkel P. A normative microbiome is not restored following kidney transplantation. Clin Sci (Lond). 2023;137(20):1563–1575. doi:10.1042/CS20230779.
   PubMed Web of Science ®Google Scholar
• Wang M, Li XS, Wang Z, de Oliveira Otto MC, Lemaitre RN, Fretts A, Sotoodehnia N, Budoff M, Nemet I, DiDonato JA. et al. Trimethylamine N-oxide is associated with long-term mortality risk: the multi-ethnic study of atherosclerosis. Eur Heart J. 2023;44(18):1608–1618. doi:10.1093/eurheartj/ehad089.
   PubMedGoogle Scholar
• McClelland R, Christensen K, Mohammed S, McGuinness D, Cooney J, Bakshi A, Demou E, MacDonald E, Caslake M, Stenvinkel P. et al. Accelerated ageing and renal dysfunction links lower socioeconomic status and dietary phosphate intake. Aging (Albany NY). 2016;8(5):1135–1149. doi:10.18632/aging.100948.
   PubMedGoogle Scholar
• Lim YJ, Sidor NA, Tonial NC, Che A, Urquhart BL. Uremic toxins in the progression of chronic kidney disease and cardiovascular disease: mechanisms and therapeutic targets. Toxins. 2021;13(2):142. doi:10.3390/toxins13020142.
   PubMed Web of Science ®Google Scholar
• Cao C, Zhu H, Yao Y, Zeng R. Gut dysbiosis and kidney diseases. Front Med. 2022;9:829349. doi:10.3389/fmed.2022.829349.
   Web of Science ®Google Scholar
• Dou L, Jourde-Chiche N, Faure V, Cerini C, Berland Y, Dignat-George F, Brunet P. The uremic solute indoxyl sulfate induces oxidative stress in endothelial cells. J Thromb Haemost. 2007;5(6):1302–1308. doi:10.1111/j.1538-7836.2007.02540.x.
   PubMed Web of Science ®Google Scholar
• Sun CY, Chang SC, Wu MS. Uremic toxins induce kidney fibrosis by activating intrarenal renin–angiotensin–aldosterone system associated epithelial-to-mesenchymal transition. PloS One. 2012;7(3):e34026. doi:10.1371/journal.pone.0034026.
   PubMed Web of Science ®Google Scholar
• Li T, Gua C, Wu B, Chen Y. Increased circulating trimethylamine N-oxide contributes to endothelial dysfunction in a rat model of chronic kidney disease. Biochem Biophys Res Commun. 2018;495(2):2071–2077. doi:10.1016/j.bbrc.2017.12.069.
   PubMed Web of Science ®Google Scholar
• Six I, Flissi N, Lenglet G, Louvet L, Kamel S, Gallet M, Massy ZA, Liabeuf S. Uremic toxins and vascular dysfunction. Toxins. 2020;12(6):12. doi:10.3390/toxins12060404.
   Web of Science ®Google Scholar
• Nemet I, Saha PP, Gupta N, Zhu W, Romano KA, Skye SM, Cajka T, Mohan ML, Li L, Wu Y. et al. A cardiovascular disease-linked gut microbial metabolite acts via adrenergic receptors. Cell. 2020;180(5):862–77.e22. doi:10.1016/j.cell.2020.02.016.
   PubMed Web of Science ®Google Scholar
• Dai L, Schurgers LJ, Shiels PG, Stenvinkel P. Early vascular ageing in chronic kidney disease: impact of inflammation, vitamin K, senescence and genomic damage. Nephrol Dial Transplant. 2020;35(Supplement_2):ii31–ii37. doi:10.1093/ndt/gfaa006.
   PubMedGoogle Scholar
• Cobo G, Lindholm B, Stenvinkel P. Chronic inflammation in end-stage renal disease and dialysis. Nephrol Dial Transplant. 2018;33(suppl_3):iii35–iii40. doi:10.1093/ndt/gfy175.
   PubMed Web of Science ®Google Scholar
• Kovesdy CP. Epidemiology of chronic kidney disease: an update 2022. Kidney Int Suppl. 2022;12(1):7–11. 2011. doi:10.1016/j.kisu.2021.11.003.
   PubMed Web of Science ®Google Scholar
• Jankowski J, Floege J, Fliser D, Böhm M, Marx N. Cardiovascular disease in chronic kidney disease: pathophysiological insights and therapeutic options. Circulation. 2021;143(11):1157–1172. doi:10.1161/CIRCULATIONAHA.120.050686.
   PubMed Web of Science ®Google Scholar
• Harlacher E, Wollenhaupt J, Baaten CCFM, Noels H. Impact of uremic toxins on endothelial dysfunction in chronic kidney disease: a systematic review. IJMS. 2022;23(1):23. doi:10.3390/ijms23010531.
   Google Scholar
• Filipska I, Winiarska A, Knysak M, Stompór T. Contribution of gut microbiota-derived uremic toxins to the cardiovascular system mineralization. Toxins. 2021;13(4):274. doi:10.3390/toxins13040274.
   PubMed Web of Science ®Google Scholar
• Yamada S, Giachelli CM. Vascular calcification in CKD-MBD: Roles for phosphate, FGF23, and Klotho. Bone. 2017;100:87–93. doi:10.1016/j.bone.2016.11.012.
   PubMed Web of Science ®Google Scholar
• Burke SK. Phosphate is a uremic toxin. J Ren Nutr. 2008;18(1):27–32. doi:10.1053/j.jrn.2007.10.007.
   PubMed Web of Science ®Google Scholar
• Duque EJ, Elias RM, Moysés RMA. Parathyroid hormone: a uremic toxin. Toxins. 2020;12(3):12. doi:10.3390/toxins12030189.
   Web of Science ®Google Scholar
• Yin L, Li X, Ghosh S, Xie C, Chen J, Huang H. Role of gut microbiota-derived metabolites on vascular calcification in CKD. J Cell Mol Med. 2021;25(3):1332–1341. doi:10.1111/jcmm.16230.
   PubMed Web of Science ®Google Scholar
• Zhang H, Chen J, Shen Z, Gu Y, Xu L, Hu J, Zhang X, Ding X. Indoxyl sulfate accelerates vascular smooth muscle cell calcification via microRNA-29b dependent regulation of Wnt/β-catenin signaling. Toxicol Lett. 2018;284:29–36. doi:10.1016/j.toxlet.2017.11.033.
   PubMed Web of Science ®Google Scholar
• Yazdekhasti N, Brandsch C, Schmidt N, Schloesser A, Huebbe P, Rimbach G, Stangl GI. Fish protein increases circulating levels of trimethylamine-N-oxide and accelerates aortic lesion formation in apoE null mice. Mol Nutr Food Res. 2016;60(2):358–368. doi:10.1002/mnfr.201500537.
   PubMed Web of Science ®Google Scholar
• Tang WH, Wang Z, Levison BS, Koeth RA, Britt EB, Fu X, Wu Y, Hazen SL. Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. N Engl J Med. 2013;368(17):1575–1584. doi:10.1056/NEJMoa1109400.
   PubMed Web of Science ®Google Scholar
• Meyer KA, Benton TZ, Bennett BJ, Jacobs DR, Lloyd-Jones DM, Gross MD, Carr JJ, Gordon‐Larsen P, Zeisel SH. Microbiota-dependent metabolite trimethylamine N-Oxide and coronary artery calcium in the Coronary Artery Risk Development in Young Adults Study (CARDIA). J Am Heart Assoc. 2016;5(10):e003970. doi:10.1161/JAHA.116.003970.
   PubMed Web of Science ®Google Scholar
• Kaysen GA, Johansen KL, Chertow GM, Dalrymple LS, Kornak J, Grimes B, Dwyer T, Chassy AW, Fiehn O. Associations of trimethylamine N-Oxide with nutritional and inflammatory biomarkers and cardiovascular outcomes in patients new to dialysis. J Ren Nutr. 2015;25(4):351–356. doi:10.1053/j.jrn.2015.02.006.
   PubMed Web of Science ®Google Scholar
• Stubbs JR, Stedman MR, Liu S, Long J, Franchetti Y, West RE, Prokopienko AJ, Mahnken JD, Chertow GM, Nolin TD. et al. Trimethylamine N-Oxide and cardiovascular outcomes in patients with ESKD receiving maintenance hemodialysis. Clin J Am Soc Nephrol. 2019;14(2):261–267. doi:10.2215/CJN.06190518.
   PubMed Web of Science ®Google Scholar
• Evenepoel P, Glorieux G, Meijers B. P-cresol sulfate and indoxyl sulfate: some clouds are gathering in the uremic toxin sky. Kidney Int. 2017;92(6):1323–1324. doi:10.1016/j.kint.2017.06.029.
   PubMed Web of Science ®Google Scholar
• Zeng Y, Guo M, Fang X, Teng F, Tan X, Li X, Wang M, Long Y, Xu Y. Gut microbiota-derived trimethylamine N-Oxide and kidney function: a systematic review and meta-analysis. Adv Nutr. 2021;12(4):1286–1304. doi:10.1093/advances/nmab010.
   PubMed Web of Science ®Google Scholar
• Tang WH, Wang Z, Kennedy DJ, Wu Y, Buffa JA, Agatisa-Boyle B, Li XS, Levison BS, Hazen SL. Gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease. Circ Res. 2015;116(3):448–455. doi:10.1161/CIRCRESAHA.116.305360.
   PubMed Web of Science ®Google Scholar
• Benoit SW, Ciccia EA, Devarajan P. Cystatin C as a biomarker of chronic kidney disease: latest developments. Expert Rev Mol Diagn. 2020;20(10):1019–1026. doi:10.1080/14737159.2020.1768849.
   PubMed Web of Science ®Google Scholar
• Lan HY, Chung AC. TGF-β/Smad signaling in kidney disease. Semin Nephrol. 2012;32(3):236–243. doi:10.1016/j.semnephrol.2012.04.002.
   PubMed Web of Science ®Google Scholar
• Zhou Z, Jin H, Ju H, Sun M, Chen H, Li L. Circulating Trimethylamine-N-Oxide and risk of all-cause and cardiovascular mortality in patients with chronic kidney disease: a systematic review and meta-analysis. Front Med. 2022;9:828343. doi:10.3389/fmed.2022.828343.
   Web of Science ®Google Scholar
• Han JM, Guo L, Chen XH, Xie Q, Song XY, Ma YL. Relationship between trimethylamine N-oxide and the risk of hypertension in patients with cardiovascular disease: A meta-analysis and dose-response relationship analysis. Medicine (Baltimore). 2024;103(1):e36784. doi:10.1097/MD.0000000000036784.
   PubMed Web of Science ®Google Scholar
• Wang L, Nan Y, Zhu W, Wang S. Effect of TMAO on the incidence and prognosis of cerebral infarction: a systematic review and meta-analysis. Front Neurol. 2023;14:1287928. doi:10.3389/fneur.2023.1287928.
   PubMed Web of Science ®Google Scholar
• Yang Y, Li X, Wang P, Shu S, Liu B, Liang Y, Yang B, Zhao Z, Luo Q, Liu Z. et al. The significance of dynamic monitoring plasma TMAO level in pulmonary arterial hypertension – a cohort study. Ther Adv Respir Dis. 2024;18:17534666231224692. doi:10.1177/17534666231224692.
   Web of Science ®Google Scholar
• Hsu BG, Wang CH, Lin YL, Lai YH, Tsai JP. Serum Trimethylamine N-Oxide level is associated with peripheral arterial stiffness in advanced non-dialysis chronic kidney disease patients. Toxins. 2022;14(8):14. doi:10.3390/toxins14080526.
   Web of Science ®Google Scholar
• Gupta N, Buffa JA, Roberts AB, Sangwan N, Skye SM, Li L, Ho KJ, Varga J, DiDonato JA, Tang WHW. et al. Targeted inhibition of gut microbial trimethylamine N-Oxide production reduces renal tubulointerstitial fibrosis and functional impairment in a murine model of chronic kidney disease. Arterioscler Thromb Vasc Biol. 2020;40(5):1239–1255. doi:10.1161/ATVBAHA.120.314139.
   PubMed Web of Science ®Google Scholar
• Brunt VE, Casso AG, Gioscia-Ryan RA, Sapinsley ZJ, Ziemba BP, Clayton ZS, Bazzoni AE, VanDongen NS, Richey JJ, Hutton DA. et al. Gut microbiome-derived metabolite trimethylamine N-Oxide induces aortic stiffening and increases systolic blood pressure with aging in mice and humans. Hypertension. 2021;78(2):499–511. doi:10.1161/HYPERTENSIONAHA.120.16895.
   PubMed Web of Science ®Google Scholar
• Agus A, Planchais J, Sokol H. Gut microbiota regulation of tryptophan metabolism in health and disease. Cell Host Microbe. 2018;23(6):716–724. doi:10.1016/j.chom.2018.05.003.
   PubMed Web of Science ®Google Scholar
• Lin X, Liang W, Li L, Xiong Q, He S, Zhao J, Guo X, Xiang S, Zhang P, Wang H. et al. The accumulation of gut microbiome–derived indoxyl sulfate and P-Cresyl sulfate in patients with end-stage renal disease. J Ren Nutr. 2022;32(5):578–586. doi:10.1053/j.jrn.2021.09.007.
   PubMed Web of Science ®Google Scholar
• Hubbard TD, Murray IA, Perdew GH. Indole and tryptophan metabolism: endogenous and dietary routes to Ah receptor activation. Drug Metab Dispos. 2015;43(10):1522–1535. doi:10.1124/dmd.115.064246.
   PubMed Web of Science ®Google Scholar
• Nakano T, Katsuki S, Chen M, Decano JL, Halu A, Lee LH, Pestana DVS, Kum AST, Kuromoto RK, Golden WS. et al. Uremic toxin indoxyl sulfate promotes proinflammatory macrophage activation via the interplay of OATP2B1 and Dll4-Notch Signaling. Circulation. 2019;139(1):78–96. doi:10.1161/CIRCULATIONAHA.118.034588.
   PubMed Web of Science ®Google Scholar
• Opdebeeck B, Maudsley S, Azmi A, De Mare A, De Leger W, Meijers B, Verhulst A, Evenepoel P, D’Haese PC, Neven E. et al. Indoxyl sulfate and p-cresyl sulfate promote vascular calcification and associate with glucose intolerance. J Am Soc Nephrol. 2019;30(5):751–766. doi:10.1681/ASN.2018060609.
   PubMed Web of Science ®Google Scholar
• Yamaguchi K, Yisireyili M, Goto S, Kato K, Cheng XW, Nakayama T, Matsushita T, Niwa T, Murohara T, Takeshita K. et al. Indoxyl sulfate-induced vascular calcification is mediated through altered notch signaling pathway in vascular smooth muscle cells. Int J Med Sci. 2020;17(17):2703–2717. doi:10.7150/ijms.43184.
   PubMed Web of Science ®Google Scholar
• Stockler-Pinto MB, Soulage CO, Borges NA, Cardozo LFMF, Dolenga CJ, Nakao LS, Pecoits-Filho R, Fouque D, Mafra D. From bench to the hemodialysis clinic: protein-bound uremic toxins modulate NF-κB/Nrf2 expression. Int Urol Nephrol. 2018;50(2):347–354. doi:10.1007/s11255-017-1748-y.
   PubMed Web of Science ®Google Scholar
• Goettsch C, Rauner M, Pacyna N, Hempel U, Bornstein SR, Hofbauer LC. miR-125b regulates calcification of vascular smooth muscle cells. Am J Pathol. 2011;179(4):1594–1600. doi:10.1016/j.ajpath.2011.06.016.
   PubMed Web of Science ®Google Scholar
• Shimizu H, Hirose Y, Goto S, Nishijima F, Zrelli H, Zghonda N, Niwa T, Miyazaki H. Indoxyl sulfate enhances angiotensin II signaling through upregulation of epidermal growth factor receptor expression in vascular smooth muscle cells. Life Sci. 2012;91(5–6):172–177. doi:10.1016/j.lfs.2012.06.033.
   PubMed Web of Science ®Google Scholar
• Barreto FC, Barreto DV, Liabeuf S, Meert N, Glorieux G, Temmar M, Choukroun G, Vanholder R, Massy ZA. Serum indoxyl sulfate is associated with vascular disease and mortality in chronic kidney disease patients. Clin J Am Soc Nephrol. 2009;4(10):1551–1558. doi:10.2215/CJN.03980609.
   PubMed Web of Science ®Google Scholar
• Muteliefu G, Enomoto A, Jiang P, Takahashi M, Niwa T. Indoxyl sulphate induces oxidative stress and the expression of osteoblast-specific proteins in vascular smooth muscle cells. Nephrol Dial Transplant. 2009;24(7):2051–2058. doi:10.1093/ndt/gfn757.
   PubMed Web of Science ®Google Scholar
• Muteliefu G, Shimizu H, Enomoto A, Nishijima F, Takahashi M, Niwa T. Indoxyl sulfate promotes vascular smooth muscle cell senescence with upregulation of p53, p21, and prelamin a through oxidative stress. Am J Physiol Cell Physiol. 2012;303(2):C126–34. doi:10.1152/ajpcell.00329.2011.
   PubMed Web of Science ®Google Scholar
• Schulman G, Vanholder R, Niwa T. AST-120 for the management of progression of chronic kidney disease. Int J Nephrol Renovasc Dis. 2014;7:49–56. doi:10.2147/IJNRD.S41339.
   PubMedGoogle Scholar
• Dou L, Bertrand E, Cerini C, Faure V, Sampol J, Vanholder R, Berland Y, Brunet P. The uremic solutes p-cresol and indoxyl sulfate inhibit endothelial proliferation and wound repair. Kidney Int. 2004;65(2):442–451. doi:10.1111/j.1523-1755.2004.00399.x.
   PubMed Web of Science ®Google Scholar
• Wang CH, Lai YH, Kuo CH, Lin YL, Tsai JP, Hsu BG. Association between serum indoxyl sulfate levels and endothelial function in non-dialysis chronic kidney disease. Toxins. 2019;11(10):11. doi:10.3390/toxins11100589.
   PubMed Web of Science ®Google Scholar
• Claro LM, Moreno-Amaral AN, Gadotti AC, Dolenga CJ, Nakao LS, Azevedo MLV, de Noronha L, Olandoski M, de Moraes T, Stinghen A. et al. The impact of uremic toxicity induced inflammatory response on the cardiovascular burden in chronic kidney disease. Toxins. 2018;10(10):10. doi:10.3390/toxins10100384.
   Web of Science ®Google Scholar
• Adijiang A, Goto S, Uramoto S, Nishijima F, Niwa T. Indoxyl sulphate promotes aortic calcification with expression of osteoblast-specific proteins in hypertensive rats. Nephrol Dial Transplant. 2008;23(6):1892–1901. doi:10.1093/ndt/gfm861.
   PubMed Web of Science ®Google Scholar
• Gross P, Massy ZA, Henaut L, Boudot C, Cagnard J, March C, Kamel S, Drueke TB, Six I. Para-cresyl sulfate acutely impairs vascular reactivity and induces vascular remodeling. J Cell Physiol. 2015;230(12):2927–2935. doi:10.1002/jcp.25018.
   PubMed Web of Science ®Google Scholar
• Lai YH, Wang CH, Kuo CH, Lin YL, Tsai JP, Hsu BG. Serum P-cresyl sulfate is a predictor of central arterial stiffness in patients on maintenance hemodialysis. Toxins. 2019;12(1):12. doi:10.3390/toxins12010010.
   PubMed Web of Science ®Google Scholar
• Wu IW, Hsu KH, Lee CC, Sun CY, Hsu HJ, Tsai CJ, Tzen C-Y, Wang Y-C, Lin C-Y, Wu M-S. et al. P-Cresyl sulphate and indoxyl sulphate predict progression of chronic kidney disease. Nephrol Dial Transplant. 2011;26(3):938–947. doi:10.1093/ndt/gfq580.
   PubMed Web of Science ®Google Scholar
• Watanabe H, Miyamoto Y, Honda D, Tanaka H, Wu Q, Endo M, Noguchi T, Kadowaki D, Ishima Y, Kotani S. et al. P-Cresyl sulfate causes renal tubular cell damage by inducing oxidative stress by activation of NADPH oxidase. Kidney Int. 2013;83(4):582–592. doi:10.1038/ki.2012.448.
   PubMed Web of Science ®Google Scholar
• Liabeuf S, Barreto DV, Barreto FC, Meert N, Glorieux G, Schepers E, Temmar M, Choukroun G, Vanholder R, Massy ZA. et al. Free p-cresylsulphate is a predictor of mortality in patients at different stages of chronic kidney disease. Nephrol Dial Transplant. 2010;25(4):1183–1191. doi:10.1093/ndt/gfp592.
   PubMed Web of Science ®Google Scholar
• Rossi M, Campbell KL, Johnson DW, Stanton T, Vesey DA, Coombes JS, Weston KS, Hawley CM, McWhinney BC, Ungerer JPJ. et al. Protein-bound uremic toxins, inflammation and oxidative stress: a cross-sectional study in stage 3–4 chronic kidney disease. Arch Med Res. 2014;45(4):309–317. doi:10.1016/j.arcmed.2014.04.002.
   PubMed Web of Science ®Google Scholar
• Vanholder R, Schepers E, Pletinck A, Nagler EV, Glorieux G. The uremic toxicity of indoxyl sulfate and p-cresyl sulfate: a systematic review. J Am Soc Nephrol. 2014;25(9):1897–1907. doi:10.1681/ASN.2013101062.
   PubMed Web of Science ®Google Scholar
• Asano Y, Nakazawa A, Endo K, Hibino Y, Ohmori M, Numao N, Kondo K. Phenylalanine dehydrogenase of Bacillus badius. Purification, characterization and gene cloning. Eur J Biochem. 1987;168(1):153–159. doi:10.1111/j.1432-1033.1987.tb13399.x.
   PubMedGoogle Scholar
• Mavrides C, Orr W. Multispecific aspartate and aromatic amino acid aminotransferases in Escherichia coli. J Biol Chem. 1975;250(11):4128–4133. doi:10.1016/S0021-9258(19)41395-1.
   PubMed Web of Science ®Google Scholar
• Smith EA, Macfarlane GT. Formation of phenolic and indolic compounds by anaerobic bacteria in the human large intestine. Microb Ecol. 1997;33(3):180–188. doi:10.1007/s002489900020.
   PubMed Web of Science ®Google Scholar
• Mayrand D. Identification of clinical isolates of selected species of bacteroides: production of phenylacetic acid. Can J Microbiol. 1979;25(8):927–928. doi:10.1139/m79-138.
   PubMed Web of Science ®Google Scholar
• Bhuiyan MS, Ellett F, Murray GL, Kostoulias X, Cerqueira GM, Schulze KE, Mahamad Maifiah MH, Li J, Creek DJ, Lieschke GJ. et al. Acinetobacter baumannii phenylacetic acid metabolism influences infection outcome through a direct effect on neutrophil chemotaxis. Proc Natl Acad Sci U S A. 2016;113(34):9599–9604. doi:10.1073/pnas.1523116113.
   PubMed Web of Science ®Google Scholar
• Scott T, Ward P, Dawson R. The formation and metabolism of phenyl-substituted fatty acids in the ruminant. Biochem J. 1964;90(1):12–24. doi:10.1042/bj0900012.
   PubMed Web of Science ®Google Scholar
• Poesen R, Claes K, Evenepoel P, de Loor H, Augustijns P, Kuypers D, Meijers B. Microbiota-derived phenylacetylglutamine associates with overall mortality and cardiovascular disease in patients with CKD. J Am Soc Nephrol. 2016;27(11):3479–3487. doi:10.1681/ASN.2015121302.
   PubMed Web of Science ®Google Scholar
• Liu Y, Liu S, Zhao Z, Song X, Qu H, Liu H. Phenylacetylglutamine is associated with the degree of coronary atherosclerotic severity assessed by coronary computed tomographic angiography in patients with suspected coronary artery disease. Atherosclerosis. 2021;333:75–82. doi:10.1016/j.atherosclerosis.2021.08.029.
   PubMed Web of Science ®Google Scholar
• Ottosson F, Brunkwall L, Smith E, Orho-Melander M, Nilsson PM, Fernandez C, Melander O. The gut microbiota-related metabolite phenylacetylglutamine associates with increased risk of incident coronary artery disease. J Hypertens. 2020;38(12):2427–2434. doi:10.1097/HJH.0000000000002569.
   PubMedGoogle Scholar
• Pan W, Kang Y. Gut microbiota and chronic kidney disease: implications for novel mechanistic insights and therapeutic strategies. Int Urol Nephrol. 2018;50(2):289–299. doi:10.1007/s11255-017-1689-5.
   PubMed Web of Science ®Google Scholar
• Franceschi C, Garagnani P, Parini P, Giuliani C, Santoro A. Inflammaging: a new immune–metabolic viewpoint for age-related diseases. Nat Rev Endocrinol. 2018;14(10):576–590. doi:10.1038/s41574-018-0059-4.
   PubMed Web of Science ®Google Scholar
• Hobson S, Arefin S, Witasp A, Hernandez L, Kublickiene K, Shiels PG, Stenvinkel P. Accelerated vascular aging in chronic kidney disease: the potential for novel therapies. Circ Res. 2023;132(8):950–969. doi:10.1161/CIRCRESAHA.122.321751.
   PubMed Web of Science ®Google Scholar
• Kooman JP, Kotanko P, Schols AM, Shiels PG, Stenvinkel P. Chronic kidney disease and premature ageing. Nat Rev Nephrol. 2014;10(12):732–742. doi:10.1038/nrneph.2014.185.
   PubMed Web of Science ®Google Scholar
• Stenvinkel P, Larsson TE. Chronic kidney disease: a clinical model of premature aging. Am J Kidney Dis. 2013;62(2):339–351. doi:10.1053/j.ajkd.2012.11.051.
   PubMed Web of Science ®Google Scholar
• Jovanovich A, Isakova T, Stubbs J. Microbiome and Cardiovascular Disease in CKD. Clin J Am Soc Nephrol. 2018;13(10):1598–1604. doi:10.2215/CJN.12691117.
   PubMed Web of Science ®Google Scholar
• Erlinger TP, Tarver-Carr ME, Powe NR, Appel LJ, Coresh J, Eberhardt MS, Brancati FL. Leukocytosis, hypoalbuminemia, and the risk for chronic kidney disease in US adults. Am J Kidney Dis. 2003;42(2):256–263. doi:10.1016/S0272-6386(03)00650-4.
   PubMed Web of Science ®Google Scholar
• Fried L, Solomon C, Shlipak M, Seliger S, Stehman-Breen C, Bleyer AJ, Chaves P, Furberg C, Kuller L, Newman A. et al. Inflammatory and prothrombotic markers and the progression of renal disease in elderly individuals. J Am Soc Nephrol. 2004;15(12):3184–3191. doi:10.1097/01.ASN.0000146422.45434.35.
   PubMed Web of Science ®Google Scholar
• Kshirsagar AV, Bomback AS, Bang H, Gerber LM, Vupputuri S, Shoham DA, Mazumdar M, Ballantyne CM, Paparello JJ, Klemmer PJ. et al. Association of C-reactive protein and microalbuminuria (from the National Health and Nutrition Examination Surveys, 1999 to 2004). Am J Cardiol. 2008;101(3):401–406. doi:10.1016/j.amjcard.2007.08.041.
   PubMed Web of Science ®Google Scholar
• Tripepi G, Mallamaci F, Zoccali C. Inflammation markers, adhesion molecules, and all-cause and cardiovascular mortality in patients with ESRD: searching for the best risk marker by multivariate modeling. J Am Soc Nephrol. 2005;16 Suppl 1(3_suppl_1):S83–8. doi:10.1681/ASN.2004110972.
   PubMedGoogle Scholar
• Yang T, Richards EM, Pepine CJ, Raizada MK. The gut microbiota and the brain–gut–kidney axis in hypertension and chronic kidney disease. Nat Rev Nephrol. 2018;14(7):442–456. doi:10.1038/s41581-018-0018-2.
   PubMed Web of Science ®Google Scholar
• Bistoletti M, Bosi A, Banfi D, Giaroni C, Baj A. The microbiota-gut-brain axis: Focus on the fundamental communication pathways. Prog Mol Biol Transl Sci. 2020;176:43–110.
   PubMed Web of Science ®Google Scholar
• Vallianou NG, Mitesh S, Gkogkou A, Geladari E. Chronic kidney disease and cardiovascular disease: is there any relationship? Curr Cardiol Rev. 2019;15(1):55–63. doi:10.2174/1573403X14666180711124825.
   PubMed Web of Science ®Google Scholar
• Sabatino A, Regolisti G, Cosola C, Gesualdo L, Fiaccadori E. Intestinal microbiota in type 2 diabetes and chronic kidney disease. Curr Diab Rep. 2017;17(3):16. doi:10.1007/s11892-017-0841-z.
   PubMed Web of Science ®Google Scholar
• Brito JS, Borges NA, Esgalhado M, Magliano DAC, Soulage CO, Mafra D. Aryl hydrocarbon receptor activation in chronic kidney disease: role of uremic toxins. NEF. 2017;137(1):1–7. doi:10.1159/000476074.
   Google Scholar
• Salvadori M, Tsalouchos A. Microbiota, renal disease and renal transplantation. World J Transplant. 2021;11(3):16–36. doi:10.5500/wjt.v11.i3.16.
   PubMedGoogle Scholar
• Hobson S, Arefin S, Rahman A, Hernandez L, Ebert T, de Loor H, Evenepoel P, Stenvinkel P, Kublickiene K. Indoxyl sulphate retention is associated with microvascular endothelial dysfunction after kidney transplantation. Int J Mol Sci. 2023;24(4):3640. doi:10.3390/ijms24043640.
   PubMed Web of Science ®Google Scholar
• Bobot M, Thomas L, Moyon A, Fernandez S, McKay N, Balasse L, Garrigue P, Brige P, Chopinet S, Poitevin S. et al. Uremic toxic blood-brain barrier disruption mediated by ahr activation leads to cognitive impairment during experimental renal dysfunction. J Am Soc Nephrol. 2020;31(7):1509–1521. doi:10.1681/ASN.2019070728.
   PubMed Web of Science ®Google Scholar
• Cryan JF, Dinan TG. Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat Rev Neurosci. 2012;13(10):701–712. doi:10.1038/nrn3346.
   PubMed Web of Science ®Google Scholar
• Osadchiy V, Martin CR, Mayer EA. Gut Microbiome and Modulation of CNS Function. Compr Physiol. 2019;10:57–72.
   PubMed Web of Science ®Google Scholar
• Jašarević E, Morrison KE, Bale TL. Sex differences in the gut microbiome–brain axis across the lifespan. Phil Trans R Soc B. 2016;371(1688):20150122. doi:10.1098/rstb.2015.0122.
   PubMed Web of Science ®Google Scholar
• Erny D, Hrabě de Angelis AL, Jaitin D, Wieghofer P, Staszewski O, David E, Keren-Shaul H, Mahlakoiv T, Jakobshagen K, Buch T. et al. Host microbiota constantly control maturation and function of microglia in the CNS. Nat Neurosci. 2015;18(7):965–977. doi:10.1038/nn.4030.
   PubMed Web of Science ®Google Scholar
• Li Y, Hao Y, Fan F, Zhang B. The role of microbiome in insomnia, circadian disturbance and depression. Front Psychiatry. 2018;9:669. doi:10.3389/fpsyt.2018.00669.
   PubMed Web of Science ®Google Scholar
• Flikkema J. The relationship between the gut microbiome and sleep examined through associated human disease. 2022.
   Google Scholar
• Bailey MT, Cryan JF. The microbiome as a key regulator of brain, behavior and immunity: Commentary on the 2017 named series. Brain Behav Immun. 2017;66:18–22. doi:10.1016/j.bbi.2017.08.017.
   PubMed Web of Science ®Google Scholar
• Sharma P, Agrawal A. Does modern research validate the ancient wisdom of gut flora and brain connection? A literature review of gut dysbiosis in neurological and neurosurgical disorders over the last decade. Neurosurg Rev. 2022;45(1):27–48. doi:10.1007/s10143-021-01516-2.
   PubMed Web of Science ®Google Scholar
• Chen JJ, Zheng P, Liu YY, Zhong XG, Wang HY, Guo YJ, Xie P. Sex differences in gut microbiota in patients with major depressive disorder. Neuropsychiatr Dis Treat. 2018;14:647–655. doi:10.2147/NDT.S159322.
   PubMed Web of Science ®Google Scholar
• Agganis BT, Weiner DE, Giang LM, Scott T, Tighiouart H, Griffith JL, Sarnak MJ. Depression and cognitive function in maintenance hemodialysis patients. Am J Kidney Dis. 2010;56(4):704–712. doi:10.1053/j.ajkd.2010.04.018.
   PubMed Web of Science ®Google Scholar
• Amira O. Prevalence of symptoms of depression among patients with chronic kidney disease. Niger J Clin Pract. 2011;14(4):460–463. doi:10.4103/1119-3077.91756.
   PubMed Web of Science ®Google Scholar
• Bautovich A, Katz I, Smith M, Loo CK, Harvey SB. Depression and chronic kidney disease: A review for clinicians. Aust N Z J Psychiatry. 2014;48(6):530–541. doi:10.1177/0004867414528589.
   PubMed Web of Science ®Google Scholar
• Shirazian S. Depression in CKD: Understanding the mechanisms of disease. Kidney Int Rep. 2019;4(2):189–190. doi:10.1016/j.ekir.2018.11.013.
   PubMed Web of Science ®Google Scholar
• Pistollato F, Sumalla Cano S, Elio I, Masias Vergara M, Giampieri F, Battino M. Role of gut microbiota and nutrients in amyloid formation and pathogenesis of Alzheimer disease. Nutr Rev. 2016;74(10):624–634. doi:10.1093/nutrit/nuw023.
   PubMed Web of Science ®Google Scholar
• Daulatzai MA. Chronic functional bowel syndrome enhances gut-brain axis dysfunction, neuroinflammation, cognitive impairment, and vulnerability to dementia. Neurochem Res. 2014;39(4):624–644. doi:10.1007/s11064-014-1266-6.
   PubMed Web of Science ®Google Scholar
• Tang W, Zhu H, Feng Y, Guo R, Wan D. The impact of gut microbiota disorders on the blood-brain barrier. Infect Drug Resist. 2020;13:3351–3363. doi:10.2147/IDR.S254403.
   PubMed Web of Science ®Google Scholar
• de Weerth C. Do bacteria shape our development? Crosstalk between intestinal microbiota and HPA axis. Neurosci Biobehav Rev. 2017;83:458–471. doi:10.1016/j.neubiorev.2017.09.016.
   PubMed Web of Science ®Google Scholar
• Bravo JA, Forsythe P, Chew MV, Escaravage E, Savignac HM, Dinan TG, Bienenstock J, Cryan JF. Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc Natl Acad Sci USA. 2011;108(38):16050–16055. doi:10.1073/pnas.1102999108.
   PubMed Web of Science ®Google Scholar
• Sudo N. Microbiome, HPA axis and production of endocrine hormones in the gut. Adv Exp Med Biol. 2014;817:177–194.
   PubMed Web of Science ®Google Scholar
• Strandwitz P. Neurotransmitter modulation by the gut microbiota. Brain Res. 2018;1693:128–133. doi:10.1016/j.brainres.2018.03.015.
   PubMed Web of Science ®Google Scholar
• Sorboni SG, Moghaddam HS, Jafarzadeh-Esfehani R, Soleimanpour S. A comprehensive review on the role of the gut microbiome in human neurological disorders. Clin Microbiol Rev. 2022;35(1):e0033820. doi:10.1128/CMR.00338-20.
   PubMed Web of Science ®Google Scholar
• Özoğul F. Production of biogenic amines by Morganella morganii, Klebsiella pneumoniae and Hafnia alvei using a rapid HPLC method. Eur Food Res Technol. 2004;219(5):465–469. doi:10.1007/s00217-004-0988-0.
   Web of Science ®Google Scholar
• Wall R, Cryan JF, Ross RP, Fitzgerald GF, Dinan TG, Stanton C. Bacterial neuroactive compounds produced by psychobiotics. Adv Exp Med Biol. 2014;817:221–239.
   PubMed Web of Science ®Google Scholar
• Barandouzi ZA, Lee J, Del Carmen Rosas M, Chen J, Henderson WA, Starkweather AR, Cong XS. Associations of neurotransmitters and the gut microbiome with emotional distress in mixed type of irritable bowel syndrome. Sci Rep. 2022;12(1):1648. doi:10.1038/s41598-022-05756-0.
   PubMed Web of Science ®Google Scholar
• Tette FM, Kwofie SK, Wilson MD. Therapeutic anti-depressant potential of microbial GABA produced by lactobacillus rhamnosus strains for GABAergic signaling restoration and inhibition of addiction-induced HPA axis hyperactivity. Curr Issues Mol Biol. 2022;44(4):1434–1451. doi:10.3390/cimb44040096.
   PubMed Web of Science ®Google Scholar
• Bercik P, Park AJ, Sinclair D, Khoshdel A, Lu J, Huang X, Deng Y, Blennerhassett PA, Fahnestock M, Moine D. et al. The anxiolytic effect of Bifidobacterium longum NCC3001 involves vagal pathways for gut-brain communication. Neurogastroenterol Motil. 2011;23(12):1132–1139. doi:10.1111/j.1365-2982.2011.01796.x.
   PubMed Web of Science ®Google Scholar
• Park SJ, Kim DH, Kang HJ, Shin M, Yang S-Y, Yang J, Jung YH. Enhanced production of γ-aminobutyric acid (GABA) using Lactobacillus plantarum EJ2014 with simple medium composition. LWT. 2021;137:110443. doi:10.1016/j.lwt.2020.110443.
   Web of Science ®Google Scholar
• Yano Y, O’Donnell CJ, Kuller L, Kavousi M, Erbel R, Ning H, D’Agostino R, Newman AB, Nasir K, Hofman A. et al. Association of coronary artery calcium score vs age with cardiovascular risk in older adults: an analysis of pooled population-based studies. JAMA Cardiol. 2017;2(9):986–994. doi:10.1001/jamacardio.2017.2498.
   PubMed Web of Science ®Google Scholar
• Sharon G, Sampson TR, Geschwind DH, Mazmanian SK. The central nervous system and the gut microbiome. Cell. 2016;167(4):915–932. doi:10.1016/j.cell.2016.10.027.
   PubMed Web of Science ®Google Scholar
• Braniste V, Al-Asmakh M, Kowal C, Anuar F, Abbaspour A, Toth M, Korecka A, Bakocevic N, Ng LG, Kundu P. et al. The gut microbiota influences blood-brain barrier permeability in mice. Sci Transl Med. 2014;6(263):263ra158. doi:10.1126/scitranslmed.3009759.
   PubMed Web of Science ®Google Scholar
• Dong F, Perdew GH. The aryl hydrocarbon receptor as a mediator of host-microbiota interplay. Gut Microbes. 2020;12(1):1859812. doi:10.1080/19490976.2020.1859812.
   PubMed Web of Science ®Google Scholar
• Adelibieke Y, Shimizu H, Muteliefu G, Bolati D, Niwa T. Indoxyl sulfate induces endothelial cell senescence by increasing reactive oxygen species production and p53 activity. J Ren Nutr. 2012;22(1):86–89. doi:10.1053/j.jrn.2011.10.027.
   PubMed Web of Science ®Google Scholar
• Colombo G, Astori E, Landoni L, Garavaglia ML, Altomare A, Lionetti MC, Gagliano N, Giustarini D, Rossi R, Milzani A. et al. Effects of the uremic toxin indoxyl sulphate on human microvascular endothelial cells. J Appl Toxicol. 2022;42(12):1948–1961. doi:10.1002/jat.4366.
   PubMed Web of Science ®Google Scholar
• Nakagawa K, Itoya M, Takemoto N, Matsuura Y, Tawa M, Matsumura Y, Ohkita M. Indoxyl sulfate induces ROS production via the aryl hydrocarbon receptor-NADPH oxidase pathway and inactivates NO in vascular tissues. Life Sci. 2021;265:118807. doi:10.1016/j.lfs.2020.118807.
   PubMed Web of Science ®Google Scholar
• Moon Y, Lim C, Kim Y, Moon WJ. Sex-related differences in regional blood–brain barrier integrity in non-demented elderly subjects. Int J Mol Sci. 2021;22(6):22. doi:10.3390/ijms22062860.
   Web of Science ®Google Scholar
• Lai Y-R, Cheng B-C, Lin C-N, Chiu W-C, Lin T-Y, Chiang H-C, Kuo CEA, Huang C-C, Lu C-H. The effects of indoxyl sulfate and oxidative stress on the severity of peripheral nerve dysfunction in patients with chronic kidney diseases. Antioxidants. 2022;11(12):2350. doi:10.3390/antiox11122350.
   Web of Science ®Google Scholar
• Navar E, Benayoun BA, Sampathkumar N, Chae J. Investigating the role of Ahr in mediating sex differences of aging macrophages. Innov Aging. 2019;3(Supplement_1):S836. doi:10.1093/geroni/igz038.3080.
   Google Scholar
• Pluznick JL. Microbial short-chain fatty acids and blood pressure regulation. Curr Hypertens Rep. 2017;19(4):25. doi:10.1007/s11906-017-0722-5.
   PubMed Web of Science ®Google Scholar
• Wu Y, Xu H, Tu X, Gao Z. The role of short-chain fatty acids of gut microbiota origin in hypertension. Front Microbiol. 2021;12:730809. doi:10.3389/fmicb.2021.730809.
   PubMed Web of Science ®Google Scholar
• Poll BG, Cheema MU, Pluznick JL. Gut microbial metabolites and blood pressure regulation: focus on SCFAs and TMAO. Physiology (Bethesda). 2020;35(4):275–284. doi:10.1152/physiol.00004.2020.
   PubMed Web of Science ®Google Scholar
• Wehedy E, Shatat IF, Al Khodor S. The human microbiome in chronic kidney disease: a double-edged sword. Front Med. 2021;8:790783. doi:10.3389/fmed.2021.790783.
   Google Scholar
• Gryp T, Huys GRB, Joossens M, Van Biesen W, Glorieux G, Vaneechoutte M. Isolation and quantification of uremic toxin precursor-generating gut bacteria in chronic kidney disease patients. Int J Mol Sci. 2020;21(6):21. doi:10.3390/ijms21061986.
   Web of Science ®Google Scholar
• Massy ZA, Chesnaye NC, Larabi IA, Dekker FW, Evans M, Caskey FJ, Torino C, Porto G, Szymczak M, Drechsler C. et al. The relationship between uremic toxins and symptoms in older men and women with advanced chronic kidney disease. Clin Kidney J. 2022;15(4):798–807. doi:10.1093/ckj/sfab262.
   PubMed Web of Science ®Google Scholar
• Fricke WF, Maddox C, Song Y, Bromberg JS. Human microbiota characterization in the course of renal transplantation. Am J Transplant. 2014;14(2):416–427. doi:10.1111/ajt.12588.
   PubMed Web of Science ®Google Scholar
• Lee JR, Muthukumar T, Dadhania D, Toussaint NC, Ling L, Pamer E, Suthanthiran M. Gut microbial community structure and complications after kidney transplantation: a pilot study. Transplantation. 2014;98(7):697–705. doi:10.1097/TP.0000000000000370.
   PubMed Web of Science ®Google Scholar
• Swarte JC, Douwes RM, Hu S, Vich Vila A, Eisenga MF, van Londen M, Gomes-Neto AW, Weersma RK, Harmsen HJM, Bakker SJL. et al. Characteristics and dysbiosis of the gut microbiome in renal transplant recipients. J Clin Med. 2020;9(2):386. doi:10.3390/jcm9020386.
   PubMed Web of Science ®Google Scholar
• Arnold R, Issar T, Krishnan AV, Pussell BA. Neurological complications in chronic kidney disease. JRSM Cardiovasc Dis. 2016;5:2048004016677687. doi:10.1177/2048004016677687.
   Web of Science ®Google Scholar
• Su H, Liu B, Chen H, Zhang T, Huang T, Liu Y, Wang C, Ma Q, Wang Q, Lv Z. et al. LncRNA ANRIL mediates endothelial dysfunction through BDNF downregulation in chronic kidney disease. Cell Death Disease. 2022;13(7):661. doi:10.1038/s41419-022-05068-1.
   PubMed Web of Science ®Google Scholar
• Colucci-D’Amato L, Speranza L, Volpicelli F. Neurotrophic factor BDNF, physiological functions and therapeutic potential in depression, neurodegeneration and brain cancer. Int J Mol Sci. 2020;21(20):21. doi:10.3390/ijms21207777.
   Web of Science ®Google Scholar
• Sudo N, Chida Y, Aiba Y, Sonoda J, Oyama N, Yu XN, Kubo C, Koga Y. Postnatal microbial colonization programs the hypothalamic–pituitary–adrenal system for stress response in mice. J Physiol. 2004;558(1):263–275. doi:10.1113/jphysiol.2004.063388.
   PubMed Web of Science ®Google Scholar
• Kreinin A, Lisson S, Nesher E, Schneider J, Bergman J, Farhat K, Farah J, Lejbkowicz F, Yadid G, Raskin L. et al. Blood BDNF level is gender specific in severe depression. PloS One. 2015;10(5):e0127643. doi:10.1371/journal.pone.0127643.
   PubMed Web of Science ®Google Scholar
• Hernandez L, Ward LJ, Arefin S, Ebert T, Laucyte-Cibulskiene A, Collaborators G-F, Norris CM, Raparelli V, Kautzky-Willer A, Herrero MT. et al. Blood–brain barrier and gut barrier dysfunction in chronic kidney disease with a focus on circulating biomarkers and tight junction proteins. Sci Rep. 2022;12(1):4414–. doi:10.1038/s41598-022-08387-7.
   PubMed Web of Science ®Google Scholar
• Hernandez L, Ward LJ, Arefin S, Barany P, Wennberg L, Söderberg M, Bruno S, Cantaluppi V, Stenvinkel P, Kublickiene K. et al. Blood–brain barrier biomarkers before and after Kidney Transplantation. Int J Mol Sci. 2023;24(7):6628. doi:10.3390/ijms24076628.
   PubMed Web of Science ®Google Scholar
• Sekercioglu N, Curtis B, Murphy S, Barrett B. Sleep quality and its correlates in patients with chronic kidney disease: a cross-sectional design. Ren Fail. 2015;37(5):757–762. doi:10.3109/0886022X.2015.1024555.
   PubMed Web of Science ®Google Scholar
• Mujahid M, Nasir K, Qureshi R, Dhrolia M, Ahmad A. Comparison of the quality of sleep in patients with chronic kidney disease and end-stage renal disease. Cureus. 2022;14:e23862. doi:10.7759/cureus.23862.
   PubMedGoogle Scholar
• Chattu VK, Manzar MD, Kumary S, Burman D, Spence DW, Pandi-Perumal SR. The global problem of insufficient sleep and its serious public health implications. Healthcare (Basel). 2018;7(1):1. doi:10.3390/healthcare7010001.
   PubMedGoogle Scholar
• Feng Q, Chen WD, Wang YD. Gut microbiota: an integral moderator in health and disease. Front Microbiol. 2018;9:151. doi:10.3389/fmicb.2018.00151.
   PubMed Web of Science ®Google Scholar
• Bellikci-Koyu E, Sarer-Yurekli BP, Akyon Y, Ozgen AG, Brinkmann A, Nitsche A, Ergunay K, Yilmaz E, St-Onge MP, Buyuktuncer Z. et al. Associations of sleep quality and night eating behaviour with gut microbiome composition in adults with metabolic syndrome. Proc Nutr Soc. 2021;80(OCE2):80. doi:10.1017/S0029665121000707.
   Web of Science ®Google Scholar
• Benedict C, Vogel H, Jonas W, Woting A, Blaut M, Schurmann A, Cedernaes J. Gut microbiota and glucometabolic alterations in response to recurrent partial sleep deprivation in normal-weight young individuals. Mol Metab. 2016;5(12):1175–1186. doi:10.1016/j.molmet.2016.10.003.
   PubMed Web of Science ®Google Scholar
• Godos J, Ferri R, Caraci F, Cosentino FII, Castellano S, Galvano F, Grosso G. Adherence to the mediterranean diet is associated with better sleep quality in italian adults. Nutrients. 2019;11(5):11. doi:10.3390/nu11050976.
   Web of Science ®Google Scholar
• Merra G, Noce A, Marrone G, Cintoni M, Tarsitano MG, Capacci A, De Lorenzo A. Influence of mediterranean diet on human gut microbiota. Nutrients. 2020;13(1):13. doi:10.3390/nu13010007.
   PubMed Web of Science ®Google Scholar
• Barber TM, Kabisch S, Pfeiffer AFH, Weickert MO. The effects of the mediterranean diet on health and gut microbiota. Nutrients. 2023;15(9):15. doi:10.3390/nu15092150.
   Web of Science ®Google Scholar
• Nigam G, Camacho M, Chang ET, Riaz M. Exploring sleep disorders in patients with chronic kidney disease. Nat Sci Sleep. 2018;10:35–43. doi:10.2147/NSS.S125839.
   PubMed Web of Science ®Google Scholar
• Saji N, Murotani K, Hisada T, Tsuduki T, Sugimoto T, Kimura A, Niida S, Toba K, Sakurai T. The relationship between the gut microbiome and mild cognitive impairment in patients without dementia: a cross-sectional study conducted in Japan. Sci Rep. 2019;9(1):19227. doi:10.1038/s41598-019-55851-y.
   PubMedGoogle Scholar
• Fan KC, Lin CC, Liu YC, Chao YP, Lai YJ, Chiu YL, Chuang YF. Altered gut microbiota in older adults with mild cognitive impairment: a case-control study. Front Aging Neurosci. 2023;15:1162057. doi:10.3389/fnagi.2023.1162057.
   PubMedGoogle Scholar
• Thancharoen O, Waleekhachonloet O, Limwattananon C, Anutrakulchai S. Cognitive impairment, quality of life and healthcare utilization in patients with chronic kidney disease stages 3 to 5. Nephrology (Carlton). 2020;25(8):625–633. doi:10.1111/nep.13705.
   PubMed Web of Science ®Google Scholar
• Tang X, Han YP, Chai YH, Gong HJ, Xu H, Patel I, Qiao Y-S, Zhang J-Y, Cardoso MA, Zhou J-B. et al. Association of kidney function and brain health: A systematic review and meta-analysis of cohort studies. Ageing Res Rev. 2022;82:101762. doi:10.1016/j.arr.2022.101762.
   PubMed Web of Science ®Google Scholar
• Ruitenberg A, den Heijer T, Bakker SL, van Swieten JC, Koudstaal PJ, Hofman A, Breteler MM. Cerebral hypoperfusion and clinical onset of dementia: the Rotterdam Study. Ann Neurol. 2005;57(6):789–794. doi:10.1002/ana.20493.
   PubMed Web of Science ®Google Scholar
• Oh ES, Freeberg KA, Steele CN, Wang W, Farmer-Bailey H, Coppock ME, Seals DR, Chonchol M, Rossman MJ, Craighead DH. et al. Cerebrovascular pulsatility index is higher in chronic kidney disease. Physiol Rep. 2023;11(1):e15561. doi:10.14814/phy2.15561.
   PubMed Web of Science ®Google Scholar
• Drew DA, Weiner DE, Sarnak MJ. Cognitive Impairment in CKD: Pathophysiology, Management, and Prevention. Am J Kidney Dis. 2019;74(6):782–790. doi:10.1053/j.ajkd.2019.05.017.
   PubMed Web of Science ®Google Scholar
• Tryc AB, Alwan G, Bokemeyer M, Goldbecker A, Hecker H, Haubitz M, Weissenborn K. Cerebral metabolic alterations and cognitive dysfunction in chronic kidney disease. Nephrol Dial Transplant. 2011;26(8):2635–2641. doi:10.1093/ndt/gfq729.
   PubMed Web of Science ®Google Scholar
• Chen G, Zhang X, Chen F. A cross-sectional study on gut microbiota in patients with chronic kidney disease undergoing kidney transplant or hemodialysis. Am J Transl Res. 2023;15:1756–1765.
   PubMed Web of Science ®Google Scholar
• Timmons JG, Manners R, Bailey M, McDougall C. Cognitive impairment reversed by cinacalcet administration in primary hyperparathyroidism. Hormones (Athens). 2021;20(3):587–589. doi:10.1007/s42000-021-00292-4.
   PubMedGoogle Scholar
• Lizio R, Babiloni C, Del Percio C, Losurdo A, Verno L, De Tommaso M, Montemurno A, Dalfino G, Cirillo P, Soricelli A. et al. Different abnormalities of cortical neural synchronization mechanisms in patients with mild cognitive impairment due to Alzheimer’s and chronic kidney diseases: an EEG study. J Alzheimers Dis. 2018;65(3):897–915. doi:10.3233/JAD-180245.
   PubMed Web of Science ®Google Scholar
• Valeri F, Endres K. How biological sex of the host shapes its gut microbiota. Front Neuroendocrinol. 2021;61:100912. doi:10.1016/j.yfrne.2021.100912.
   PubMed Web of Science ®Google Scholar
• Jazani NH, Savoj J, Lustgarten M, Lau WL, Vaziri ND. Impact of gut dysbiosis on neurohormonal pathways in chronic kidney disease. Diseases. 2019;7(1):21. doi:10.3390/diseases7010021.
   PubMedGoogle Scholar
• UNICEF. The state of food security and nutrition in the world 2021. 2021.
   Google Scholar
• Organization WH. Global health observatory (GHO) data. 2015.
   Google Scholar
• Vermeulen SJ, Campbell BM, Ingram JS. Climate change and food systems. Annu Rev Environ Resour. 2012;37(1):195–222. doi:10.1146/annurev-environ-020411-130608.
   Google Scholar
• Clark MA, Domingo NGG, Colgan K, Thakrar SK, Tilman D, Lynch J, Azevedo IL, Hill JD. Global food system emissions could preclude achieving the 1.5° and 2°C climate change targets. Science. 2020;370(6517):705–708. doi:10.1126/science.aba7357.
   PubMed Web of Science ®Google Scholar
• Clark MA, Springmann M, Hill J, Tilman D. Multiple health and environmental impacts of foods. Proc Natl Acad Sci U S A. 2019;116(46):23357–23362. doi:10.1073/pnas.1906908116.
   PubMed Web of Science ®Google Scholar
• Stenvinkel P, Shiels PG, Johnson RJ. Lessons from evolution by natural selection: An unprecedented opportunity to use biomimetics to improve planetary health. J Environ Manage. 2023;328:116981. doi:10.1016/j.jenvman.2022.116981.
   PubMed Web of Science ®Google Scholar